Cointime

CinCor Pharma

company

About

CinCor is a clinical-stage biopharmaceutical company that develops treatments for cardiovascular diseases.

  • 11 - 50

Highlights

Total Funding Amount
$143M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series B
Last Funding Money Raised
$143M
Industries
Biotechnology,Pharmaceutical,Therapeutics
Founded date
Jan 1, 2018
Number Of Employee
11 - 50
Operating Status
Active

CinCor is a clinical-stage biopharmaceutical company with a mission to advance promising clinical candidates toward marketing approval. CinCor’s focus is on cardiovascular, metabolic and kidney diseases. CinCor’s lead program is CIN-107, a novel aldosterone synthase inhibitor.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$143M
CinCor Pharma has raised a total of $143M in funding over 2 rounds. Their latest funding was raised on Oct 12, 2021 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 12, 2021 Series B $143M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
CinCor Pharma is funded by 1 investors. Lilly Asia Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Lilly Asia Ventures — Series B
Cointime
เนื้อหา
บริษัท